ABSTRACT

Objective: Interferon therapy is widely used for patients with chronic viral hepatitis B and C (CHB-C). It is known that thyroid gland dysfunction (TD) may develop secondary to interferon treatment, but different frequencies of TD development are reported in the literature. For this reason, we aimed to investigate the incidence of TD developing secondary to interferon treat ment in patients with CHB-C, treated in our clinic, and identify possible influencing factors.